EUPATI welcomes 53 participants to educational program on medicines' R&D
The European Patients’ Academy (EUPATI) is proud to announce the start of the first Patient Expert Training Course. This is one of EUPATI’s key educational programmes specifically designed to meet the needs of patients and patient representatives and to impart expert-level knowledge about the whole spectrum of the medicine research and development process. Last week, a webinar marked the official opening of the Course and the launch of the online learning programs for 53 participants.
“We are excited to start the first Patient Expert Training Course. This unique EUPATI educational program offers patients and patient representatives training across the medicine research and development process. The Course is specifically designed to meet the needs of participants who are motivated with the skill set to acquire and apply this expert-level knowledge,” said Jan Geissler, EUPATI Director.
The EUPATI Patient Expert Training Course is a mixture of online and face-to-face training and covers all aspects of the medicine research and development process including discovery, development, evaluation, marketing authorization and post-marketing evaluation. Over the 15-month training period, participants will take six e-learning modules covering a broad range of topics. Participants will also attend two face-to-face training events for interactive teaching as well as the opportunity to meet directly with other patient experts and with specialists working in the field of medicine development.
The Patient Expert Training Course aims to encourage participants to apply knowledge and skills acquired through three main areas:
The second wave of the Expert Patient Training Course will start in September 2015. By 2016, there will be over 100 Expert Patients who will be able to share their expertise and help to reach the patient community, raise public awareness and generate dialogue around future patient involvement in the medicine research and development.
About Participant Selection
The selection of participants for the first Patient Expert Training Course (2014-2015) was done via a transparent process:EUPATI received more than 300 applications for the course. An Independent Evaluation Panel selected 53 participants based upon careful examination of all eligible applications against the pre-defined selection criteria. The application period for next year's EUPATI Patient Expert Training Course (2015-2016) will start in spring 2015. Details will be available on the EUPATI website.
Unlock Commercial Growth through Data-Driven Patient and HCP Insights
May 2nd 2025Leveraging data-driven patient and healthcare provider (HCP) insights, including social drivers of health (SDOH), is essential for life sciences companies to continuously improve patient engagement and commercial success. Mark Rodgers, AVP of Commercial Analytics at Inovalon, discusses how identifying treatment milestones, assessing HCP performance, and segmenting patient populations using SDOH data can drive targeted strategies that improve healthcare outcomes and market access
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
FDA Approves Nipocalimab for the Treatment of Generalized Myasthenia Gravis
April 30th 2025Approval is based on results from the pivotal Vivacity-MG3 trial in which IMAAVY (nipocalimab-aahu) demonstrated superior disease control throughout 24 weeks when compared to placebo plus standard of care.